X-132628920-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001394073.1(HS6ST2):c.1241C>A(p.Pro414His) variant causes a missense change. The variant allele was found at a frequency of 0.0000397 in 1,209,599 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000054 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000038 ( 0 hom. 14 hem. )
Consequence
HS6ST2
NM_001394073.1 missense
NM_001394073.1 missense
Scores
2
3
12
Clinical Significance
Conservation
PhyloP100: 6.81
Genes affected
HS6ST2 (HGNC:19133): (heparan sulfate 6-O-sulfotransferase 2) Heparan sulfate proteoglycans are ubiquitous components of the cell surface, extracellular matrix, and basement membranes, and interact with various ligands to influence cell growth, differentiation, adhesion, and migration. This gene encodes a member of the heparan sulfate (HS) sulfotransferase gene family, which catalyze the transfer of sulfate to HS. Different family members and isoforms are thought to synthesize heparan sulfates with tissue-specific structures and functions. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.368236).
BS2
High Hemizygotes in GnomAdExome4 at 14 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HS6ST2 | NM_001394073.1 | c.1241C>A | p.Pro414His | missense_variant | 5/5 | ENST00000370833.7 | NP_001381002.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HS6ST2 | ENST00000370833.7 | c.1241C>A | p.Pro414His | missense_variant | 5/5 | 5 | NM_001394073.1 | ENSP00000359870 |
Frequencies
GnomAD3 genomes AF: 0.0000537 AC: 6AN: 111713Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33893
GnomAD3 genomes
AF:
AC:
6
AN:
111713
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33893
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000664 AC: 12AN: 180762Hom.: 0 AF XY: 0.0000746 AC XY: 5AN XY: 66990
GnomAD3 exomes
AF:
AC:
12
AN:
180762
Hom.:
AF XY:
AC XY:
5
AN XY:
66990
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000383 AC: 42AN: 1097886Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 14AN XY: 363370
GnomAD4 exome
AF:
AC:
42
AN:
1097886
Hom.:
Cov.:
31
AF XY:
AC XY:
14
AN XY:
363370
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000537 AC: 6AN: 111713Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33893
GnomAD4 genome
AF:
AC:
6
AN:
111713
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33893
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
8
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2022 | The c.1241C>A (p.P414H) alteration is located in exon 6 (coding exon 5) of the HS6ST2 gene. This alteration results from a C to A substitution at nucleotide position 1241, causing the proline (P) at amino acid position 414 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;.;T;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.;N;.
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.;.;.
REVEL
Benign
Sift
Benign
D;D;.;.;.
Sift4G
Uncertain
D;D;D;D;.
Polyphen
B;.;.;B;.
Vest4
MutPred
Loss of methylation at K376 (P = 0.1068);.;.;Loss of methylation at K376 (P = 0.1068);.;
MVP
MPC
0.71
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at